A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

NCT ID: NCT06527404

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

469 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-18

Study Completion Date

2027-01-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prurigo Nodularis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A: Blinded Treatment

Participants will receive rocatinlimab dose 1 subcutaneously (SC) during Treatment Period A and B.

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

SC Injection

Arm B: Blinded Treatment

Participants will receive rocatinlimab dose 2 SC during Treatment Period A and B.

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

SC Injection

Arm C: Blinded Treatment

Participants will receive matching placebo SC during Treatment Period A and B.

Group Type EXPERIMENTAL

Placebo

Intervention Type DRUG

SC Injection

Arm D: Open-label

Participants will receive open-label rocatinlimab dose 1 SC during Treatment Period B.

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

SC Injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rocatinlimab

SC Injection

Intervention Type DRUG

Placebo

SC Injection

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AMG 451

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years (or any legal adult age within the country if it is older than 18 years)
* Clinical Diagnosis of Prurigo Nodularis that has been present for at least 3 months.
* Patient-reported average Daily Itch Score based on electronic daily diary assessment the last 7 days prior to and including day 1.
* Has ≥ 20 prurigo nodularis nodules in total with bilateral distribution on both legs and /or arms and /or trunk.
* History of inadequate response to topical therapies of medium or higher potency or for whom topical treatments are otherwise medically inadvisable (eg, because of important side effects or safety risks).

Exclusion Criteria

* Skin or systemic morbidities, other than prurigo nodularis, that have been active within the last 3 months that interfere with assessment of study outcomes including but not limited to atopic dermatitis (signs or symptoms other than dry skin or requiring treatment is not allowed; use of emollients and/or history of AD is allowed).
* Prurigo nodularis secondary to medications.
* Prurigo nodularis secondary to neurologic or psychiatric medical conditions.
* Treatment with any systemic biologic immunosuppressive or systemic biologic immunomodulatory therapy for prurigo nodularis or any other autoimmune, inflammatory, or allergic disease within 12 weeks or 5 half-lives, whichever is longer, prior to day 1 prerandomization.
* Treatment with live virus including live attenuated vaccination 12 weeks prior to day 1 prerandomization.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

First OC Dermatology

Fountain Valley, California, United States

Site Status

Los Angeles Universal Research Center

Los Angeles, California, United States

Site Status

Paradigm Clinical Research Center Inc

San Diego, California, United States

Site Status

Wolverine Clinical Trials

Santa Ana, California, United States

Site Status

Direct Helpers Research Center

Hialeah, Florida, United States

Site Status

Southern Clinical Research

Miami, Florida, United States

Site Status

University of Miami Hospital

Miami, Florida, United States

Site Status

Miami Dermatology and Laser Institute

Miami, Florida, United States

Site Status

Wellness Clinical Research

Miami Lakes, Florida, United States

Site Status

Clinical Research Trials of Florida Inc

Tampa, Florida, United States

Site Status

Olympian Clinical Research - Tampa

Tampa, Florida, United States

Site Status

Emory University

Atlanta, Georgia, United States

Site Status

Endeavor Health Clinical Trials Center

Skokie, Illinois, United States

Site Status

The Indiana Clinical Trials Center PC

Plainfield, Indiana, United States

Site Status

Revival Research Institute, LLC

Troy, Michigan, United States

Site Status

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Site Status

Optima Research

Boardman, Ohio, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

Wright State Physicians

Fairborn, Ohio, United States

Site Status

Hightower Clinical

Oklahoma City, Oklahoma, United States

Site Status

Center For Clinical Studies PLLC

Houston, Texas, United States

Site Status

Clarity Dermatology

Lancaster, Texas, United States

Site Status

Springville Dermatology

Springville, Utah, United States

Site Status

Hospital Universitario Austral

Derqui, Pilar, Buenos Aires, Argentina

Site Status

Instituto de Investigaciones Clinicas de Cordoba

Córdoba, Córdoba Province, Argentina

Site Status

Instituto de Neumonologia y Dermatologia

Buenos Aires, Distrito Federal, Argentina

Site Status

Derma Internacional

Buenos Aires, Distrito Federal, Argentina

Site Status

Centro de investigacion clinica y epidemiologica

San Miguel D Tucuman, Tucumán Province, Argentina

Site Status

Parra Dermatologia

Mendoza, , Argentina

Site Status

St George Dermatology and Skin Cancer Centre

Kogarah, New South Wales, Australia

Site Status

Veracity Clinical Research

Woolloongabba, Queensland, Australia

Site Status

Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

The Alfred Hospital

Melbourne, Victoria, Australia

Site Status

The Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Medizinische Universitaet Graz

Graz, , Austria

Site Status

Ordensklinikum Linz Elisabethinen

Linz, , Austria

Site Status

Universite Catholique de Louvain Cliniques Universitaires Saint Luc

Brussels, , Belgium

Site Status

Universitaire Ziekenhuizen Leuven Gasthuisberg

Leuven, , Belgium

Site Status

Centre Hospitalier Universitaire de Liege - Sart Tilman

Liège, , Belgium

Site Status

Clinica Instituto Bahiano de Imunoterapia - Medicina, Reumatologia e Dermatologia ltda

Salvador, Estado de Bahia, Brazil

Site Status

Irmandade da Santa Casa de Misericordia de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Universidade Estadual Paulista Julio de Mesquita Filho

Botucatu, São Paulo, Brazil

Site Status

Fundacao Abc - Centro Univ Fmabc

Santo André, São Paulo, Brazil

Site Status

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo, São Paulo, Brazil

Site Status

IBPClin Instituto Brasil de Pesquisa Clinica

Rio de Janeiro, , Brazil

Site Status

Doctor Chih-Ho Hong Medical Incorporated

Surrey, British Columbia, Canada

Site Status

Skincare Studio

St. John's, Newfoundland and Labrador, Canada

Site Status

CCA Medical Research Corp

Ajax, Ontario, Canada

Site Status

Centricity Research London Victoria

London, Ontario, Canada

Site Status

Lovegrove Dermatology

London, Ontario, Canada

Site Status

Lynderm Research Inc

Markham, Ontario, Canada

Site Status

SKiN Centre for Dermatology

Peterborough, Ontario, Canada

Site Status

York Dermatology Clinic and Research Centre

Richmond Hill, Ontario, Canada

Site Status

Toronto Research Centre Inc

Toronto, Ontario, Canada

Site Status

AvantDerm

Toronto, Ontario, Canada

Site Status

Alliance Clinical Trials

Waterloo, Ontario, Canada

Site Status

Centre de Recherche Dermatologique du Quebec Metropolitain

Québec, Quebec, Canada

Site Status

Enroll SpA

Providencia, Santiago Metropolitan, Chile

Site Status

Centro Medico Skinmed Spa

Santiago, , Chile

Site Status

Fundacion Innovacion Cardiovascular Clinica Ensenada

Santiago, , Chile

Site Status

Centro Internacional de Estudios Clinicos

Santiago, , Chile

Site Status

Clinical Research Chile SpA

Valdivia, , Chile

Site Status

Peking University First Hospital

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

Site Status

The First Affiliated Hospital Sun-Yat Sen University

Guangzhou, Guangdong, China

Site Status

Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, China

Site Status

Nanfang Hospital Southern Medical University

Guangzhou, Guangdong, China

Site Status

The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China

Site Status

Sanmenxia Central Hospital

Sanmenxia, Henan, China

Site Status

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

Site Status

Wuxi Peoples Hospital

Wuxi, Jiangsu, China

Site Status

Dermatology Hospital of Jiangxi Province

Nanchang, Jiangxi, China

Site Status

The First Bethune Hospital of Jilin University

Changchun, Jilin, China

Site Status

The Second Affiliated Hospital Of Xi An Jiaotong University

Xi'an, Shaanxi, China

Site Status

Huashan Hospital Affiliated to Fudan University

Shanghai, Shanghai Municipality, China

Site Status

Shanghai Skin Disease Hospital

Shanghai, Shanghai Municipality, China

Site Status

Chengdu Second Peoples Hospital

Chengdu, Sichuan, China

Site Status

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Site Status

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China

Site Status

The Second Affliated Hospital of Kunming Medical University

Kunming, Yunnan, China

Site Status

Affiliated Hangzhou First Peoples Hospital School of Medicine Westlake University

Hangzhou, Zhejiang, China

Site Status

Clinical Research Services Helsinki

Helsinki, , Finland

Site Status

Oulun Yliopistollinen sairaala

Oulu, , Finland

Site Status

Terveystalo Tampere

Tampere, , Finland

Site Status

Centre Hospitalier Regional Universitaire de Brest - Hopital Morvan

Brest, , France

Site Status

Centre Hospitalier Le Mans

Le Mans, , France

Site Status

Cabinet du Docteur Ruer-Mulard Mireille

Martigues, , France

Site Status

Centre Hospitalier Universitaire Archet 2

Nice, , France

Site Status

Centre Hospitalier Universitaire de Rouen - Hopital Charles Nicolle

Rouen, , France

Site Status

Universitaetsklinikum Augsburg

Augsburg, , Germany

Site Status

Fachklinik Bad Bentheim

Bad Bentheim, , Germany

Site Status

Charite - Universitaetsmedizin Berlin, Campus Virchow

Berlin, , Germany

Site Status

Rosenpark Research GmbH

Darmstadt, , Germany

Site Status

Universitaetsklinikum Dresden

Dresden, , Germany

Site Status

Universitaetsklinikum Schleswig-Holstein - Kiel

Kiel, , Germany

Site Status

Universitaetsmedizin Mainz

Mainz, , Germany

Site Status

Universitaetsklinikum Muenster

Münster, , Germany

Site Status

Hautarztpraxis Mortazawi

Remscheid, , Germany

Site Status

Universitaetsklinikum Tuebingen

Tübingen, , Germany

Site Status

Helios Klinikum Wuppertal

Wuppertal, , Germany

Site Status

University General Hospital Attikon

Athens, , Greece

Site Status

Andreas Syngros Hospital Of Venereal And Dermatological Diseases

Athens, , Greece

Site Status

General Hospital Of Nea Ionia Konstantopouleio Patision

Nea Ionia, , Greece

Site Status

Ippokratio General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Papageorgiou General Hospital

Thessaloniki, , Greece

Site Status

Queen Mary Hospital, The University of Hong Kong

Hong Kong, , Hong Kong

Site Status

Obudai Egeszsegugyi Centrum Kft

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Derm-Surg Kft

Kaposvár, , Hungary

Site Status

DermaMed Research Kft

Orosháza, , Hungary

Site Status

Pecsi Tudomanyegyetem Klinikai Kozpont

Pécs, , Hungary

Site Status

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar

Szeged, , Hungary

Site Status

Ospedale San Salvatore

LAquila, , Italy

Site Status

Azienda Ospedaliera Luigi Sacco

Milan, , Italy

Site Status

Azienda Ospedaliero Universitaria di Modena

Modena, , Italy

Site Status

Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia

Perugia, , Italy

Site Status

Fondazione Policlinico Tor Vergata

Roma, , Italy

Site Status

Fujita Health University Hospital

Toyoake-shi, Aichi-ken, Japan

Site Status

Ogaki Municipal Hospital

Ogaki-shi, Gifu, Japan

Site Status

Medical Corporation Kojinkai Sapporo Skin Clinic

Sapporo, Hokkaido, Japan

Site Status

Mito Kyodo General Hospital

Mito, Ibaraki, Japan

Site Status

Kochi Medical School Hospital

Nankoku-shi, Kochi, Japan

Site Status

Noguchi Dermatology Clinic

Kamimashiki-gun, Kumamoto, Japan

Site Status

Nagasaki University Hospital

Nagasaki, Nagasaki, Japan

Site Status

Kawasaki Medical School Hospital

Kurashiki-shi, Okayama-ken, Japan

Site Status

Hayami Dermatology Clinic

Osaka, Osaka, Japan

Site Status

Dokkyo Medical University Saitama Medical Center

Koshigaya-shi, Saitama, Japan

Site Status

National Defense Medical College hospital

Tokorozawa-shi, Saitama, Japan

Site Status

Institute of Science Tokyo Hospital

Bunkyo-ku, Tokyo, Japan

Site Status

Tokyo Teishin Hospital

Chiyoda-ku, Tokyo, Japan

Site Status

Shirasaki Dermatology Clinic

Takaoka-shi, Toyama, Japan

Site Status

Tokyo Medical University Hospital

Shinjyuku-ku, , Japan

Site Status

J Kisis

Riga, , Latvia

Site Status

Outpatient clinic Veselibas Centrs 4

Riga, , Latvia

Site Status

Outpatient clinic Veselibascentrs 4

Riga, , Latvia

Site Status

Clínica de Enfermedades Crónicas y de Procedimientos Especiales

Morelia, Michoacán, Mexico

Site Status

Instituto de Investigaciones Aplicadas a la Neurociencia A C

Durango, , Mexico

Site Status

Universitair Medisch Centrum Utrecht

Utrecht, , Netherlands

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej

Bialystok, , Poland

Site Status

Uniwersyteckie Centrum Kliniczne

Gdansk, , Poland

Site Status

AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy

Gdansk, , Poland

Site Status

GynCentrum Spzoo NZOZ Holsamed - Oddzial Libero

Katowice, , Poland

Site Status

Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne

Lodz, , Poland

Site Status

Dermedic Jacek Zdybski

Ostrowiec Świętokrzyski, , Poland

Site Status

Uniwersytecki Szpital Kliniczny imienia Fryderyka Chopina w Rzeszowie

Rzeszów, , Poland

Site Status

Velocity Skierniewice Spolka z Ograniczona Odpowiedzialnoscia

Skierniewice, , Poland

Site Status

Centrum Zdrowia Dziecka i Rodziny Im Jana Pawla II w Sosnowcu Osrodek Badan Klinicznych

Sosnowiec, , Poland

Site Status

Royalderm Agnieszka Nawrocka

Warsaw, , Poland

Site Status

Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak Spolka Partnerska

Wroclaw, , Poland

Site Status

DermMedica Spzoo Centrum Columbus

Wroclaw, , Poland

Site Status

Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria

Lisbon, , Portugal

Site Status

Hospital Cuf Descobertas

Lisbon, , Portugal

Site Status

Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio

Porto, , Portugal

Site Status

Spitalul Clinic Judetean de Urgenta Cluj-Napoca

Cluj-Napoca, , Romania

Site Status

Spitalul Clinic Judetean Mures

Târgu Mureş, , Romania

Site Status

Korea University Ansan Hospital

Ansansi, Gyeonggido, , South Korea

Site Status

Korea University Anam Hospital

Seoul, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

Hanyang University Seoul Hospital

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Hallym University Kangnam Sacred Heart Hospital

Seoul, , South Korea

Site Status

Hospital Universitario Reina Sofia

Córdoba, Andalusia, Spain

Site Status

Hospital Universitario Miguel Servet

Zaragoza, Aragon, Spain

Site Status

Hospital Universitario de Gran Canaria Doctor Negrin

Las Palmas de Gran Canaria, Canary Islands, Spain

Site Status

Hospital Universitari Germans Trias i Pujol

Badalona, Catalonia, Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, Catalonia, Spain

Site Status

Hospital General Universitario de Alicante

Alicante, Valencia, Spain

Site Status

Hospital Universitario de La Princesa

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Diagnostiskt Centrum Hud i Sickla

Nacka, , Sweden

Site Status

Akademiska sjukhuset

Uppsala, , Sweden

Site Status

Inselspital Bern

Bern, , Switzerland

Site Status

Universitaetsspital Zuerich

Zuerich Flughafen, , Switzerland

Site Status

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Mackay Memorial Hospital Taipei Branch

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Linkou Chang Gung Memorial Hospital

Taoyuan District, , Taiwan

Site Status

Ankara Bilkent Sehir Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Adnan Menderes Universitesi Medical Faculty

Aydin, , Turkey (Türkiye)

Site Status

Pamukkale Universitesi Tip Fakultesi Hastanesi

Denizli, , Turkey (Türkiye)

Site Status

Gaziantep Universitesi Tip Fakultesi Hastanesi

Gaziantep, , Turkey (Türkiye)

Site Status

Izmir Demokrasi Universitesi Buca Seyfi Demirsoy Egitim ve Arastirma Hastanesi

Izmir, , Turkey (Türkiye)

Site Status

Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi

Samsun, , Turkey (Türkiye)

Site Status

Queen Elizabeth University Hospital

Glasgow, , United Kingdom

Site Status

Chapel Allerton Hospital

Leeds, , United Kingdom

Site Status

Royal London Hospital

London, , United Kingdom

Site Status

Guys Hospital

London, , United Kingdom

Site Status

Ameli-Biogroup Limited

Waltham Abbey, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Belgium Brazil Canada Chile China Finland France Germany Greece Hong Kong Hungary Italy Japan Latvia Mexico Netherlands Poland Portugal Romania South Korea Spain Sweden Switzerland Taiwan Turkey (Türkiye) United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20230053

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.